Stock 000627 HUBEI BIOCAUSE PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Hubei Biocause Pharmaceutical Co., Ltd.

Equities

000627

CNE000000F48

Life & Health Insurance

End-of-day quote Shenzhen S.E.
Other stock markets
 03:30:00 09/05/2024 am IST 		5-day change 1st Jan Change
2.31 CNY +0.87% Intraday chart for Hubei Biocause Pharmaceutical Co., Ltd. -2.94% -18.66%
29/04 Hubei Biocause Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
15/04 Hubei Biocause Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

Hubei Biocause Pharmaceutical Co.,Ltd. is a China-based company principally engaged in insurance business, such as life insurance, health insurance and casualty insurance. The Company is also involved in pharmaceutical business and chemical business. The Company’s products include polypropylene and Ibuprofen. The Company distributes its products in domestic market and to overseas markets, with Central China and South China as its main markets.

Number of employees: 1,765

Sales per Business

CNY in Million2022Weight2023Weight Delta
Life Insurance
96.6 %
47,735 96.2 % 47,994 96.6 % +0.54%
Health Insurance
2.6 %
1,348 2.7 % 1,274 2.6 % -5.50%
Other Business
0.9 %
532 1.1 % 431 0.9 % -19.06%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
100.0 %
49,616 100.0 % 49,699 100.0 % +0.17%

Managers

Managers TitleAgeSince
Wen Xia Zhou CEO
 Chief Executive Officer 52 26/20/26
Jian Qiang Shen CHM
 Chairman 52 01/96/01
Da Li Chen DFI
 Director of Finance/CFO 57 26/20/26
Fei Long BRD
 Director/Board Member 45 -
Meng Lian Li IRC
 Investor Relations Contact - -

Members of the board

Members of the board TitleAgeSince
Yi Qian Liu CHM
 Chairman 61 11/15/11
Yunhua Xiao BRD
 Director/Board Member 62 01/03/01
Da Li Chen DFI
 Director of Finance/CFO 57 26/20/26
Fei Long BRD
 Director/Board Member 45 -
Hai Hua Jiang BRD
 Director/Board Member 58 -
Jian Qiang Shen CHM
 Chairman 52 01/96/01
Wen Xia Zhou CEO
 Chief Executive Officer 52 26/20/26
Jun Lu BRD
 Director/Board Member 52 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 4,940,629,165 1,566,851,805 ( 31.71 %) 0 31.71 %

Shareholders

NameEquities%Valuation
Yi Qian Liu
47.18 %
2,331,033,177 47.18 % 797 M ¥
Wei Wang
11.25 %
555,604,700 11.25 % 190 M ¥
Yang Chao Wang
1.423 %
70,323,488 1.423 % 24 M ¥
Minsheng Royal Fund Management Co., Ltd.
0.9391 %
46,399,066 0.9391 % 16 M ¥
Founder Fubon Fund Management Co., Ltd.
0.3184 %
15,729,000 0.3184 % 5 M ¥
Mu Xiu Zhang
0.3036 %
15,000,000 0.3036 % 5 M ¥
Fuli Tianrui Huashang Investment Management Co. Ltd.
0.2771 %
13,690,995 0.2771 % 5 M ¥
GF Fund Management Co., Ltd.
0.1413 %
6,981,100 0.1413 % 2 M ¥
Gfund Management Co., Ltd.
0.1057 %
5,220,900 0.1057 % 2 M ¥
China Asset Management Co., Ltd.
0.1048 %
5,177,600 0.1048 % 2 M ¥
NameEquities%Valuation
Yi Qian Liu
100.00 %
388,125,000 100.00 % 133 M ¥

Company contact information

Hubei Biocause Pharmaceutical Co., Ltd.

2/F, Building 1 Guohua Huijin Center, 1 Tianshan Rd

448000, Jingmen

+

http://www.tianmaogroup.net
address Hubei Biocause Pharmaceutical Co., Ltd.(000627)

Sector

Financials
Insurance
Insurance
Life & Health Insurance
Other Life & Health Insurance

Sales per Business

Annual profits - Rate of surprise

Company calendar

Sector Other Life & Health Insurance

1st Jan change Capi.
HUBEI BIOCAUSE PHARMACEUTICAL CO., LTD. Stock Hubei Biocause Pharmaceutical Co., Ltd.
-18.66% 1.57B
AXA Stock AXA
+13.43% 78.69B
METLIFE, INC. Stock MetLife, Inc.
+9.69% 50.96B
AFLAC INCORPORATED Stock Aflac Incorporated
+3.49% 48.2B
MANULIFE FINANCIAL CORPORATION Stock Manulife Financial Corporation
+20.18% 43.97B
PRUDENTIAL FINANCIAL, INC. Stock Prudential Financial, Inc.
+13.73% 41.9B
GENERALI Stock Generali
+26.04% 39.87B
SUN LIFE FINANCIAL INC. Stock Sun Life Financial Inc.
+6.85% 30.84B
GREAT-WEST LIFECO INC. Stock Great-West Lifeco Inc.
-1.87% 29.08B
CATHAY FINANCIAL HOLDING CO., LTD. Stock Cathay Financial Holding Co., Ltd.
+13.01% 23.04B
Other Life & Health Insurance
  1. Stock Market
  2. Equities
  3. 000627 Stock
  4. Company Hubei Biocause Pharmaceutical Co., Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW